These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 24475542)
1. The impact of Wyeth v. Levine on FDA regulation of prescription drugs. Ausness RC Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542 [TBL] [Abstract][Full Text] [Related]
2. Preemption of the "fraud on the FDA" exception to Michigan's tort immunity statute for drug manufacturers: reconsidering Garcia and Desiano after Levine. Murdey J Food Drug Law J; 2011; 66(1):85-104, ii-iii. PubMed ID: 24505848 [TBL] [Abstract][Full Text] [Related]
3. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety. Kesselheim AS Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322 [TBL] [Abstract][Full Text] [Related]
4. How the FDA can overturn Wyeth v. Levine. Gostanian A Am J Law Med; 2010; 36(1):248-68. PubMed ID: 20481407 [TBL] [Abstract][Full Text] [Related]
5. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix. Smirniotopoulos A Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960 [TBL] [Abstract][Full Text] [Related]
6. Tort reform by regulation: FDA prescription drug labeling rules and preemption of state tort claims. Moreland MP J Health Life Sci Law; 2007; 1(1):39, 41-62. PubMed ID: 18610730 [TBL] [Abstract][Full Text] [Related]
7. Good law from tragic facts--Congress, the FDA, and preemption. Annas GJ N Engl J Med; 2009 Sep; 361(12):1206-11. PubMed ID: 19759383 [No Abstract] [Full Text] [Related]
8. Buckman extended: federal preemption of state fraud-on-the-FDA statutes. Gaddis CA Food Drug Law J; 2014; 69(1):113-36, iii. PubMed ID: 24772688 [TBL] [Abstract][Full Text] [Related]
9. Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers. Rostron A Duke Law J; 2011 Feb; 60(5):1123-91. PubMed ID: 21365961 [TBL] [Abstract][Full Text] [Related]
10. The demise of drug design litigation: death by federal preemption. Twerski AD Am Univ Law Rev; 2018; 68(1):281-304. PubMed ID: 30457769 [TBL] [Abstract][Full Text] [Related]
11. A strike against preemption. Nat Biotechnol; 2009 May; 27(5):397. PubMed ID: 19430422 [TBL] [Abstract][Full Text] [Related]
12. Life after Riegel: a fresh look at medical device preemption one year after Riegel v. Medtronic, Inc. Wartman GJ Food Drug Law J; 2009; 64(2):291-311. PubMed ID: 19999286 [TBL] [Abstract][Full Text] [Related]
13. FDA preemption of drug and device labeling: who should decide what goes on a drug label? Valoir T; Ghosh S Health Matrix Clevel; 2011; 21(2):555-98. PubMed ID: 22145525 [TBL] [Abstract][Full Text] [Related]
14. Guide to preemption of state-law claims against Class III PMA medical devices. Whitney DW Food Drug Law J; 2010; 65(1):113-39, ii-iii. PubMed ID: 24475536 [TBL] [Abstract][Full Text] [Related]
15. The Supreme Court, preemption, and malpractice liability. Kesselheim AS; Studdert DM N Engl J Med; 2009 Feb; 360(6):559-61. PubMed ID: 19196672 [No Abstract] [Full Text] [Related]
16. Wyeth v Levine: implications for public health policy and practice. David S; Rosenbaum S Public Health Rep; 2010; 125(3):494-7. PubMed ID: 20433045 [No Abstract] [Full Text] [Related]
17. FDA's regulation of prescription drug labeling: a role for implied preemption. Kendrick LC Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031 [No Abstract] [Full Text] [Related]
19. Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels. Boumil MM; Curfman G JAMA; 2018 Aug; 320(6):547-548. PubMed ID: 30039167 [No Abstract] [Full Text] [Related]
20. The Supreme Court's Latest Ruling on Drug Liability and its Implications for Future Failure-to-Warn Litigation. Morten CJ; Kesselheim AS; Ross JS J Law Med Ethics; 2019 Dec; 47(4):783-787. PubMed ID: 31957583 [No Abstract] [Full Text] [Related] [Next] [New Search]